Glandokort Dosage Calculator
Glandokort is a peptide bioregulator derived from the adrenal glands of young animals through acid extraction and purification.
10mcg · Daily
Summary: Add 0mL BAC water to your 10mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.
Cycle Planner
Glandokort Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~1-4 hours (estimated, short peptide complex)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Glandokort Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 10mg | 2x Daily |
| Aggressive | 20mg | 2x Daily |
Note: Glandokort is an oral peptide bioregulator containing complex A-17, a mixture of short-chain peptides extracted from the adrenal glands of young cattle or pigs. Each capsule contains approximately 10 mg of active peptides. Standard protocols use 1-2 capsules twice daily for 10-30 days, repeated 2-3 times per year.
About Glandokort
Glandokort is a peptide bioregulator derived from the adrenal glands of young animals through acid extraction and purification. The active component, peptide complex A-17, contains low-molecular-weight peptides (under 5,000 Da) that are proposed to interact selectively with adrenal cortex cells to normalize their metabolic activity. A clinical study enrolled 36 patients (ages 37-62) with chronic adrenal cortex insufficiency and prolonged stress exposure. Patients received 1 capsule twice daily for 30 days alongside standard adaptogen therapy. The study reported improvements in physical and mental performance, mood, and sleep quality compared to controls. Researchers also observed restoration of metabolic activity in the reticular adrenal zone, with increased production of aldosterone and 17-ketosteroids returning to normal-range values. This single clinical study wasn't published in an indexed peer-reviewed journal, and the evidence base remains thin by Western standards. No randomized, double-blind, placebo-controlled trials have been conducted.